LIXT
Lixte Biotechnology Holdings, Inc.Company with tickers: LIXT
CIK
1335105
CUSIP
539319301
Shares Outstanding
12,382,944
13F Activity (30d)
12 filings
12 filers
Price
$5.85
Market Cap
$72.81M
P/E Ratio
-4.64
EPS (Diluted)
$-1.26
52W High
$6.26
52W Low
$0.64
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $1,987,407 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Research & Development | $333,376 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Operating Income | $-1,987,407 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Net Income | — | ||||
| EPS (Basic) | $-0.18 | USD/shares | 2026-03-31 | 10-Q | 2026-05-14 |
| EPS (Diluted) | $-0.18 | USD/shares | 2026-03-31 | 10-Q | 2026-05-14 |